Adequacy of Endoscopic Ultrasound Core Needle Biopsy Specimen of Nonmalignant Hepatic Parenchymal Disease

Ferga C. Gleeson, Amy C. Clayton, Lizhi Zhang, Jonathan E. Clain, Gregory James Gores, Elizabeth Rajan, Thomas Christopher Smyrk, Mark Topazian, Kenneth Ke Ning Wang, Maurits J. Wiersema, Michael J. Levy

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background & Aims: The adequacy and diagnostic yield of hepatic parenchymal disease Trucut biopsy have not been determined. Therefore, our aim was to determine the adequacy of endoscopic ultrasound (EUS)-guided Trucut liver biopsy for histopathologic evaluation to include the number of complete portal tracts contained per millimeter of acquired tissue. Methods: A single institution retrospective review was made of 9 prospectively identified patients who underwent a transgastric left liver lobe EUS-guided Trucut biopsy during a 36-month period. Results: Adequate diagnostic material, to include complete portal tract number evaluation (median, 7) and connective tissue staining, was acquired to establish a histopathologic diagnosis in all 9 cases. Sixty-three complete portal tracts were established, resulting in 0.4 portal tracts per millimeter of tissue acquired. Findings established by EUS Trucut left liver lobe biopsy included mild steatosis (n = 4), cryptogenic cirrhosis (n = 2), chronic ductopenic biliary tract disease (n = 1), portal fibrosis with ductular proliferation (n = 1), and alcoholic cirrhosis with hemosiderosis (n = 1). Conclusions: EUS-guided Trucut left liver lobe biopsy yields suitable aggregate tissue for diagnostic purposes to establish the presence of chronic liver disease.

Original languageEnglish (US)
Pages (from-to)1437-1440
Number of pages4
JournalClinical Gastroenterology and Hepatology
Volume6
Issue number12
DOIs
StatePublished - Dec 2008

Fingerprint

Large-Core Needle Biopsy
Biopsy
Liver
Hemosiderosis
Biliary Tract Diseases
Alcoholic Liver Cirrhosis
Connective Tissue
Liver Diseases
Fibrosis
Chronic Disease
Staining and Labeling

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Adequacy of Endoscopic Ultrasound Core Needle Biopsy Specimen of Nonmalignant Hepatic Parenchymal Disease. / Gleeson, Ferga C.; Clayton, Amy C.; Zhang, Lizhi; Clain, Jonathan E.; Gores, Gregory James; Rajan, Elizabeth; Smyrk, Thomas Christopher; Topazian, Mark; Wang, Kenneth Ke Ning; Wiersema, Maurits J.; Levy, Michael J.

In: Clinical Gastroenterology and Hepatology, Vol. 6, No. 12, 12.2008, p. 1437-1440.

Research output: Contribution to journalArticle

Gleeson, Ferga C. ; Clayton, Amy C. ; Zhang, Lizhi ; Clain, Jonathan E. ; Gores, Gregory James ; Rajan, Elizabeth ; Smyrk, Thomas Christopher ; Topazian, Mark ; Wang, Kenneth Ke Ning ; Wiersema, Maurits J. ; Levy, Michael J. / Adequacy of Endoscopic Ultrasound Core Needle Biopsy Specimen of Nonmalignant Hepatic Parenchymal Disease. In: Clinical Gastroenterology and Hepatology. 2008 ; Vol. 6, No. 12. pp. 1437-1440.
@article{243cf22653674dceae7d3d9287eacbee,
title = "Adequacy of Endoscopic Ultrasound Core Needle Biopsy Specimen of Nonmalignant Hepatic Parenchymal Disease",
abstract = "Background & Aims: The adequacy and diagnostic yield of hepatic parenchymal disease Trucut biopsy have not been determined. Therefore, our aim was to determine the adequacy of endoscopic ultrasound (EUS)-guided Trucut liver biopsy for histopathologic evaluation to include the number of complete portal tracts contained per millimeter of acquired tissue. Methods: A single institution retrospective review was made of 9 prospectively identified patients who underwent a transgastric left liver lobe EUS-guided Trucut biopsy during a 36-month period. Results: Adequate diagnostic material, to include complete portal tract number evaluation (median, 7) and connective tissue staining, was acquired to establish a histopathologic diagnosis in all 9 cases. Sixty-three complete portal tracts were established, resulting in 0.4 portal tracts per millimeter of tissue acquired. Findings established by EUS Trucut left liver lobe biopsy included mild steatosis (n = 4), cryptogenic cirrhosis (n = 2), chronic ductopenic biliary tract disease (n = 1), portal fibrosis with ductular proliferation (n = 1), and alcoholic cirrhosis with hemosiderosis (n = 1). Conclusions: EUS-guided Trucut left liver lobe biopsy yields suitable aggregate tissue for diagnostic purposes to establish the presence of chronic liver disease.",
author = "Gleeson, {Ferga C.} and Clayton, {Amy C.} and Lizhi Zhang and Clain, {Jonathan E.} and Gores, {Gregory James} and Elizabeth Rajan and Smyrk, {Thomas Christopher} and Mark Topazian and Wang, {Kenneth Ke Ning} and Wiersema, {Maurits J.} and Levy, {Michael J.}",
year = "2008",
month = "12",
doi = "10.1016/j.cgh.2008.07.015",
language = "English (US)",
volume = "6",
pages = "1437--1440",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "12",

}

TY - JOUR

T1 - Adequacy of Endoscopic Ultrasound Core Needle Biopsy Specimen of Nonmalignant Hepatic Parenchymal Disease

AU - Gleeson, Ferga C.

AU - Clayton, Amy C.

AU - Zhang, Lizhi

AU - Clain, Jonathan E.

AU - Gores, Gregory James

AU - Rajan, Elizabeth

AU - Smyrk, Thomas Christopher

AU - Topazian, Mark

AU - Wang, Kenneth Ke Ning

AU - Wiersema, Maurits J.

AU - Levy, Michael J.

PY - 2008/12

Y1 - 2008/12

N2 - Background & Aims: The adequacy and diagnostic yield of hepatic parenchymal disease Trucut biopsy have not been determined. Therefore, our aim was to determine the adequacy of endoscopic ultrasound (EUS)-guided Trucut liver biopsy for histopathologic evaluation to include the number of complete portal tracts contained per millimeter of acquired tissue. Methods: A single institution retrospective review was made of 9 prospectively identified patients who underwent a transgastric left liver lobe EUS-guided Trucut biopsy during a 36-month period. Results: Adequate diagnostic material, to include complete portal tract number evaluation (median, 7) and connective tissue staining, was acquired to establish a histopathologic diagnosis in all 9 cases. Sixty-three complete portal tracts were established, resulting in 0.4 portal tracts per millimeter of tissue acquired. Findings established by EUS Trucut left liver lobe biopsy included mild steatosis (n = 4), cryptogenic cirrhosis (n = 2), chronic ductopenic biliary tract disease (n = 1), portal fibrosis with ductular proliferation (n = 1), and alcoholic cirrhosis with hemosiderosis (n = 1). Conclusions: EUS-guided Trucut left liver lobe biopsy yields suitable aggregate tissue for diagnostic purposes to establish the presence of chronic liver disease.

AB - Background & Aims: The adequacy and diagnostic yield of hepatic parenchymal disease Trucut biopsy have not been determined. Therefore, our aim was to determine the adequacy of endoscopic ultrasound (EUS)-guided Trucut liver biopsy for histopathologic evaluation to include the number of complete portal tracts contained per millimeter of acquired tissue. Methods: A single institution retrospective review was made of 9 prospectively identified patients who underwent a transgastric left liver lobe EUS-guided Trucut biopsy during a 36-month period. Results: Adequate diagnostic material, to include complete portal tract number evaluation (median, 7) and connective tissue staining, was acquired to establish a histopathologic diagnosis in all 9 cases. Sixty-three complete portal tracts were established, resulting in 0.4 portal tracts per millimeter of tissue acquired. Findings established by EUS Trucut left liver lobe biopsy included mild steatosis (n = 4), cryptogenic cirrhosis (n = 2), chronic ductopenic biliary tract disease (n = 1), portal fibrosis with ductular proliferation (n = 1), and alcoholic cirrhosis with hemosiderosis (n = 1). Conclusions: EUS-guided Trucut left liver lobe biopsy yields suitable aggregate tissue for diagnostic purposes to establish the presence of chronic liver disease.

UR - http://www.scopus.com/inward/record.url?scp=57149086861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57149086861&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2008.07.015

DO - 10.1016/j.cgh.2008.07.015

M3 - Article

VL - 6

SP - 1437

EP - 1440

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 12

ER -